Jerri Ann Thatcher

Jerri Ann Thatcher has worked in the life sciences industry since 1991. Jerri Ann began their career at Searle, where they held roles as Product Manager, Associate Product Manager, Medical Sales Representative, and Market Research Analyst. Jerri Ann then moved to Wyeth Pharmaceuticals in 1997, where they held the roles of Executive Director and Group Director of Vaccines Marketing, as well as Product Director and Senior Product Manager of CNS Marketing. In 2004, they joined Cephalon and held the roles of Senior Director of Pain Franchise Marketing, Senior Director of US Strategic Planning and Worldwide Product Planning, and Senior Group Director of Wake Enhancing and ADHD Franchise Marketing. In 2012, they founded JA Thatcher Consulting, where they worked as a Pharmaceutical Strategic Marketing Consultant. In 2013, they joined PRN Physician Recommended Nutriceuticals as Chief Commercial Officer and Vice President of Marketing. In 2014, they returned to JA Thatcher Consulting as a Life Sciences Strategic Marketing Consultant. In 2017, they joined Sanguis, LLC as an Executive Business Advisor for their Phase I Ventures Program. Finally, in 2018, they became the CEO of FloBio LLC.

Jerri Ann Thatcher holds a BS in Economics with a focus in Marketing/Management from The Wharton School and a Master of Business Administration (MBA) in Marketing from Washington University in St. Louis - Olin Business School.